{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:48:30Z","timestamp":1762505310617},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr. Treat. Options in Oncol."],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1007\/s11864-007-0039-8","type":"journal-article","created":{"date-parts":[[2007,12,6]],"date-time":"2007-12-06T16:14:52Z","timestamp":1196957692000},"page":"314-321","source":"Crossref","is-referenced-by-count":3,"title":["Prediction of Successful Outcome in Patients with Primary Aldosteronism"],"prefix":"10.1007","volume":"8","author":[{"given":"Tracy-Ann","family":"Moo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rasa","family":"Zarnegar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quan-Yang","family":"Duh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,12,5]]},"reference":[{"key":"39_CR1","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1093\/ndt\/gfh112","volume":"19","author":"PF Plouin","year":"2004","unstructured":"Plouin PF, Amar L, Chatellier G: Trends in the prevalence of primary aldosteronism, aldosterone-producing adenomas, and surgically correctable aldosterone-dependent hypertension. Nephrol Dial Transplant 2004, 19:774\u2013777","journal-title":"Nephrol Dial Transplant"},{"key":"39_CR2","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","volume":"48","author":"GP Rossi","year":"2006","unstructured":"Rossi GP, Bernini G, Caliumi C, et\u00a0al.: A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol 2006, 48:2293\u20132300","journal-title":"J Am Coll Cardiol"},{"key":"39_CR3","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","volume":"45","author":"P Milliez","year":"2005","unstructured":"Milliez P, Girerd X, Plouin PF, et\u00a0al.: Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol 2005, 45:1243\u20131248","journal-title":"J Am Coll Cardiol"},{"key":"39_CR4","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/HJH.0b013e3280108e6f","volume":"25","author":"G Giacchetti","year":"2007","unstructured":"Giacchetti G, Ronconi V, Turchi F, et\u00a0al.: Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study. J Hypertens 2007, 25:177\u2013186","journal-title":"J\u2423Hypertens"},{"key":"39_CR5","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1055\/s-2007-970409","volume":"115","author":"F Mantero","year":"2007","unstructured":"Mantero F, Mattarello MJ, Albiger NM: Detecting and treating primary aldosteronism: primary aldosteronism. Exp Clin Endocrinol Diabetes 2007, 115:171\u2013174","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"39_CR6","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1161\/01.HYP.37.6.1440","volume":"37","author":"M Agharazii","year":"2001","unstructured":"Agharazii M, Douville P, Grose JH, et\u00a0al.: Captopril suppression versus salt loading in confirming primary aldosteronism. Hypertension, 2001 37:1440\u20131443","journal-title":"Hypertension"},{"key":"39_CR7","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1210\/jcem.86.3.7287","volume":"86","author":"GP Rossi","year":"2001","unstructured":"Rossi GP, Sacchetto A, Chiesura-Corona M et\u00a0al.: Identification of the etiology of primary aldosteronism with adrenal vein sampling in patients with equivocal computed tomography and magnetic resonance findings: results in 104 consecutive cases. J Clin Endocrinol Metab 2001, 86:1083\u20131090","journal-title":"J Clin Endocrinol Metab"},{"key":"39_CR8","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.surg.2004.06.051","volume":"136","author":"WF Young","year":"2004","unstructured":"Young WF, Stanson AW, Thompson GB, et\u00a0al.: Role for adrenal venous sampling in primary aldosteronism. Surgery 2004, 136:1227\u20131235","journal-title":"Surgery"},{"key":"39_CR9","doi-asserted-by":"crossref","unstructured":"Tan YY, Ogilvie JB, Triponez F, et\u00a0al.: Selective use of adrenal venous sampling in the lateralization of aldosterone-producing adenomas. World J Surg 2006, 30:879\u2013885; discussion 886\u2013877","DOI":"10.1007\/s00268-005-0622-8"},{"key":"39_CR10","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s00464-002-8810-1","volume":"17","author":"KK Hallfeldt","year":"2003","unstructured":"Hallfeldt KK, Mussack T, Trupka A, et\u00a0al. Laparoscopic lateral adrenalectomy versus open posterior adrenalectomy for the treatment of benign adrenal tumors. Surg Endosc 2003, 17:264\u2013267","journal-title":"Surg Endosc"},{"key":"39_CR11","doi-asserted-by":"crossref","first-page":"258","DOI":"10.7326\/0003-4819-135-4-200108210-00010","volume":"135","author":"AM Sawka","year":"2001","unstructured":"Sawka AM, Young WF, Thompson GB, et\u00a0al.: Primary aldosteronism: factors associated with normalization of blood pressure after surgery. Ann Intern Med 2001, 135:258\u2013261","journal-title":"Ann Intern Med"},{"key":"39_CR12","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1177\/000313480707300218","volume":"73","author":"I Gockel","year":"2007","unstructured":"Gockel I, Heintz A, Polta M, et\u00a0al.: Long-term results of endoscopic adrenalectomy for Conn\u2019s syndrome. Am Surg 2007, 73:174\u2013180","journal-title":"Am Surg"},{"key":"39_CR13","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00268-004-7496-z","volume":"29","author":"A Meyer","year":"2005","unstructured":"Meyer A, Brabant G, Behrend M: Long-term follow-up after adrenalectomy for primary aldosteronism. World J Surg 2005, 29:155\u2013159","journal-title":"World J Surg"},{"key":"39_CR14","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1210\/en.2003-0279","volume":"144","author":"WF Young Jr","year":"2003","unstructured":"Young WF, Jr: Minireview: primary aldosteronism\u2014changing concepts in diagnosis and treatment. Endocrinology 2003, 44:2208\u20132213","journal-title":"Endocrinology"},{"key":"39_CR15","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1517\/14656566.7.5.563","volume":"7","author":"S Janmohamed","year":"2006","unstructured":"Janmohamed S, Bouloux PM: The pharmacological treatment of primary aldosteronism. Expert Opin Pharmacother 2006, 7:563\u2013573","journal-title":"Expert Opin Pharmacother"},{"key":"39_CR16","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/ncpneph0151","volume":"2","author":"C Mattsson","year":"2006","unstructured":"Mattsson C, Young WF, Jr: Primary aldosteronism: diagnostic and treatment strategies. Nat Clin Pract Nephrol 2006, 2:198\u2013208","journal-title":"Nat Clin Pract Nephrol"},{"key":"39_CR17","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/00004872-200103000-00001","volume":"19","author":"PO Lim","year":"2001","unstructured":"Lim PO, Young WF, MacDonald TM: A review of the medical treatment of primary aldosteronism. J Hypertens 2001, 19:353\u2013361","journal-title":"J Hypertens"},{"key":"39_CR18","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1046\/j.1365-2125.1999.00070.x","volume":"48","author":"PO Lim","year":"1999","unstructured":"Lim PO, Jung RT, MacDonald TM: Raised aldosterone to renin ratio predicts antihypertensive efficacy of spironolactone: a prospective cohort follow-up study. Br J Clin Pharmacol 1999, 48:756\u2013760","journal-title":"Br J Clin Pharmacol"},{"key":"39_CR19","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1345\/aph.1C027","volume":"36","author":"AJ Zillich","year":"2002","unstructured":"Zillich AJ, Carter BL: Eplerenone\u2014a novel selective aldosterone blocker. Ann Pharmacother 2002, 36:1567\u20131576","journal-title":"Ann Pharmacother"},{"key":"39_CR20","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0895-7061(02)02957-6","volume":"15","author":"MH Weinberger","year":"2002","unstructured":"Weinberger MH, Roniker B, Krause SL, Weiss RJ: Eplerenone, a selective aldosterone blocker, in mild-to-moderate hypertension. Am J Hypertens 2002, 15:709\u2013716","journal-title":"Am J Hypertens"},{"key":"39_CR21","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s11906-001-0058-y","volume":"3","author":"EL Bravo","year":"2001","unstructured":"Bravo EL: Medical management of primary hyperaldosteronism. Curr Hypertens Rep 2001, 3:406\u2013409","journal-title":"Curr Hypertens Rep"},{"key":"39_CR22","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1345\/aph.1H456","volume":"41","author":"CD Bubbar","year":"2007","unstructured":"Bubbar CD, Blackburn DF, Wilson MP, et\u00a0al. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in hypertension due to primary aldosteronism: a case for exclusion. Ann Pharmacother 2007, 41:129\u2013132","journal-title":"Ann Pharmacother"},{"key":"39_CR23","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1097\/00004872-200106000-00022","volume":"19","author":"GS Stokes","year":"2001","unstructured":"Stokes GS, Monaghan JC, Ryan M, et\u00a0al.: Efficacy of an angiotensin II receptor antagonist in managing hyperaldosteronism. J Hypertens 2001, 19:1161\u20131165","journal-title":"J Hypertens"},{"key":"39_CR24","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1590\/S0004-27302004000500014","volume":"48","author":"GT McMahon","year":"2004","unstructured":"McMahon GT, Dluhy RG: Glucocorticoid-remediable aldosteronism. Arq Bras Endocrinol Metabol 2004, 48:682\u2013686","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"39_CR25","first-page":"3570","volume":"82","author":"WR Litchfield","year":"1997","unstructured":"Litchfield WR, New MI, Coolidge C, et\u00a0al.: Evaluation of the dexamethasone suppression test for the diagnosis of glucocorticoid-remediable aldosteronism. J Clin Endocrinol Metab 1997, 82:3570\u20133573","journal-title":"J Clin Endocrinol Metab"},{"key":"39_CR26","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1161\/01.HYP.38.3.688","volume":"38","author":"L Mosso","year":"2001","unstructured":"Mosso L, Gomez-Sanchez CE, Foecking MF, et\u00a0al. Serum 18-hydroxycortisol in primary aldosteronism, hypertension, and normotensives. Hypertension 2001, 38:688\u2013691","journal-title":"Hypertension"},{"key":"39_CR27","doi-asserted-by":"crossref","first-page":"5814","DOI":"10.1210\/jc.2003-030530","volume":"88","author":"S Minowada","year":"2003","unstructured":"Minowada S, Fujimura T, Takahashi N, et\u00a0al. Computed tomography-guided percutaneous acetic acid injection therapy for functioning adrenocortical adenoma. J Clin Endocrinol Metab 2003, 88:5814\u20135817","journal-title":"J Clin Endocrinol Metab"},{"key":"39_CR28","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/cncr.11084","volume":"97","author":"BJ Wood","year":"2003","unstructured":"Wood BJ, Abraham J, Hvizda JL, et\u00a0al. Radiofrequency ablation of adrenal tumors and adrenocortical carcinoma metastases. Cancer 2003, 97:554\u2013560","journal-title":"Cancer"},{"key":"39_CR29","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1148\/radiol.2311031007","volume":"231","author":"WW Mayo-Smith","year":"2004","unstructured":"Mayo-Smith WW, Dupuy DE: Adrenal neoplasms: CT-guided radiofrequency ablation\u2014preliminary results. Radiology 2004, 231:225\u2013230","journal-title":"Radiology"}],"container-title":["Current Treatment Options in Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-007-0039-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11864-007-0039-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-007-0039-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,30]],"date-time":"2021-08-30T01:07:34Z","timestamp":1630285654000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11864-007-0039-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["39"],"URL":"https:\/\/doi.org\/10.1007\/s11864-007-0039-8","relation":{},"ISSN":["1527-2729","1534-6277"],"issn-type":[{"value":"1527-2729","type":"print"},{"value":"1534-6277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,8]]}}}